On February 4, President Biden issued a memorandum to agency heads on “advancing the human rights of lesbian, gay, bisexual, transgender, queer, and intersex persons around the world.”
He directed that “it shall be the policy of the United States to pursue an end to violence and discrimination on the basis of sexual orientation, gender identity or expression, or sex characteristics.”
Somewhat surprisingly, the memorandum was designated National Security Memorandum/NSM-4 and was published as such in the Federal Register on February 26.
This was unexpected since the NSM designation was not included in the original White House release on February 4, and the memorandum itself does not make any explicit reference to national security. The Biden memo builds on a 2011 Obama Memorandum which also did not invoke national security.
In effect, the defense of LGBTQI+ rights has now been elevated by the Biden Administration to a national security policy of the United States.
* * *
A January 21 White House policy on International COVID-19 Response was originally issued as National Security Directive 1.
But perhaps because the “National Security Directive” designation was previously claimed by the first Bush Administration, Biden’s NSD-1 was renamed and reissued as National Security Memorandum 1.
An unnumbered National Security Memorandum dated February 4 on Revitalizing the National Security Workforce is apparently NSM-3.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.